Abdul Mannan: Paradox of Bleeding and Clotting in Uremic Coagulopathy
Abdul Mannan, Consultant Haematologist, Director Haemophilia Centre and Haematology Lab Lead at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Your dialysis patient is bleeding from their gut.
But their clotting tests look normal.
Sound familiar?
This is uremic coagulopathy, and most people still don’t fully understand what’s going wrong at the platelet level.
Here’s what’s actually happening:
- Excess urea generates cyanate, which carbamylates the αIIbβ3 integrin on platelets.
The fibrinogen-binding site gets structurally altered. Platelet aggregation fails at the final step.
- GPIb receptors on platelets get proteolysed, reducing von Willebrand factor adhesion.
The platelet never properly sticks to the damaged vessel wall in the first place.
- Nitric oxide and prostacyclin levels are both elevated in uraemia. Both independently inhibit platelet activation. It’s a double hit.
- Anaemia makes it worse. Below a haematocrit of 25%, red blood cells can’t physically push platelets to the vessel wall (margination).
No margination, no effective primary haemostasis.
Now here’s the part that keeps me up at night.
The same uraemic toxins that cause bleeding also drive a prothrombotic state.
- Indoxyl sulfate triggers eryptosis, exposing phosphatidylserine on red blood cell membranes.
- These surfaces act as a scaffold for coagulation factor assembly and thrombin generation.
The result?
These patients bleed from their gut, clot off their fistula and stroke.
Both. At the same time.
This is why managing bleeding in a dialysis patient isn’t just about giving desmopressin and hoping for the best.
The pathophysiology is layered, and the treatment has to match it.”

More posts from Abdul Mannan on Hemostasis Today.
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge
-
Oct 19, 2026, 16:13Javier M. Floren: When Immune Cells Move With Their Environment